Catalyst Wire Dossier Catalyst Wire Dossier

Uplizna

inebilizumab · Horizon Therapeutics
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Uplizna, covering 2020-06-11 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Myasthenia Gravis Inebilizumab Trial [Phase 3]

See pricing